综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Virologist: Lab leakage claims pure fabrication

By ZHANG ZHIHAO | chinadaily.com.cn | Updated: 2020-05-26 21:00
Share
Share - WeChat

Research under pressure

Despite these safety guarantees, Yuan said the recent onslaught of conspiracy theories against the institute has brought great pressure to the researchers who are busy studying the virus and looking for a possible cure or vaccine.

"I believe it would be hard for anyone to be completely indifferent to such suspicions, rumors and even malicious, offensive remarks that are pulled out of thin air," he said.

One rumor that was particularly toxic claimed that a female postgraduate student from the institute was the "patient zero" for COVID-19. "The student had graduated in 2015, and has been working and living a normal life in another city," Yuan said. But the rumor did "irreparable damage" to her safety and privacy and that of her family, he added.

"Despite unexpected pressure and stress, my colleagues and I clearly know that defeating this virus is our top priority and responsibility, and we have worked day in and day out without holidays or weekends," he said. "Our hard work has been fully supported by Wuhan residents and the government and is recognized by the international scientific community."

The institute is conducting research on the basic biological characteristics of the novel coronavirus and its mechanism of infection, as well as drug screening and vaccine development.

The Wuhan institute, along with the Shanghai Institute of Materia Medica and ShanghaiTech University, discovered compounds with new structures that can effectively inhibit the coronavirus. The results were published online in the journal Science on April 23.

An inactivated vaccine jointly developed by the Wuhan Institute of Biological Products Co and the Wuhan Institute of Virology was approved by the National Medical Products Administration of China on April 12 and was put into clinical trials the same day.

"It is the policy of the WIV to share scientific research information in an open and timely manner," Yuan said. "The P4 lab is an indispensable support platform for these efforts.

"Conducting systematic and in-depth research on a new virus that is so cunning and hard to counter urgently requires closer communication and cooperation among international peers."

|<< Previous 1 2 3   
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
陆丰市| 安仁县| 清水河县| 双江| 杭州市| 沁水县| 西青区| 江山市| 庄河市| 白银市| 江达县| 平邑县| 闵行区| 福州市| 靖宇县| 海安县| 福安市| 拜泉县| 深水埗区| 临朐县| 南汇区| 芒康县| 广安市| 福建省| 井冈山市| 洞口县| 赞皇县| 新竹县| 信丰县| 米脂县| 台湾省| 红安县| 阳曲县| 库伦旗| 镇雄县| 扶余县| 昂仁县| 开鲁县| 柘荣县| 新干县| 义马市|